December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
A Reporter Gene Construct Containing 1.4-kb Alpha1-proteinase Inhibitor Promoter Confers Expression In The Cornea of Transgenic Mice
Author Affiliations & Notes
  • J Ueda
    Ophthalmology & Visual Sciences University of Illinois at Chicago College of Medicine Chicago IL
  • Y Li
    Ophthalmology & Visual Sciences University of Illinois at Chicago College of Medicine Chicago IL
  • MS Goh
    Ophthalmology & Visual Sciences University of Illinois at Chicago College of Medicine Chicago IL
  • Y Maruyama
    Ophthalmology & Visual Sciences University of Illinois at Chicago College of Medicine Chicago IL
  • J Sugar
    Ophthalmology & Visual Sciences University of Illinois at Chicago College of Medicine Chicago IL
  • BY J T Yue
    Ophthalmology & Visual Sciences University of Illinois at Chicago College of Medicine Chicago IL
  • Footnotes
    Commercial Relationships   J. Ueda, None; Y. Li, None; M.S. Goh, None; Y. Maruyama, None; J. Sugar, None; B.Y.J.T. Yue, None. Grant Identification: Support: NIH grants EY 03890, EY 05628, EY 01792
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3227. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J Ueda, Y Li, MS Goh, Y Maruyama, J Sugar, BY J T Yue; A Reporter Gene Construct Containing 1.4-kb Alpha1-proteinase Inhibitor Promoter Confers Expression In The Cornea of Transgenic Mice . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3227. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The alpha1-proteinase inhibitor (a1-PI) gene has been shown to be markedly downregulated in keratoconus corneas. We cloned and sequenced a 1.4-kb promoter fragment of the human a1-PI gene. This fragment was functional specifically in human corneal cells in transient transfection experiments. To extend the in vitro experimentation to in vivo, transgenic mice were produced in which the spatial and temporal expression of the a1-PI promoter was investigated. Methods: A 1.4-kb human a1-PI 5'-flanking sequence fused to the E. coli LacZ gene was used to generate transgenic mice. The corneas and various other tissues of transgenic and non-transgenic mice were immunostained with a rabbit polyclonal anti-E. coli b-galactosidase antibody. RT-PCR analyses of LacZ were also performed using RNAs extracted from the various tissues. For developmental studies, tissues from embryonic (E) and postnatal (P) transgenic mice on days E10.5, E12.5, E15.5, E18.5, P0, P7, P11 and P30 were examined immunohistochemically. Results: In transgenic mice, positive b-galactosidase staining was observed in all layers of the corneal epithelium and stroma. No staining was found in other ocular tissues, liver or kidney. Moderate to weak expression was noted in the skin, brain and white blood cells. Developmental studies indicated that the a1-PI promoter-driven LacZ expression in the corneal epithelium began at E15.5 and remained constant after E18.5. The expression in the stroma started on P7 and was the most prominent on P11. Conclusion: The 1.4-kb a1-PI fragment was found to target LacZ expression preferentially to the epithelium and stroma of the mouse cornea. This promoter may offer an option for targeting foreign genes to the cornea in future transgenic experiments for studies of epithelial-stromal interactions and diseases such as keratoconus.

Keywords: 370 cornea: basic science • 417 gene/expression • 450 keratoconus 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×